Suresh Veeramani

This paper introduces a novel RNA aptamer-based assay to quantify PD1 saturation by PDL1 in tumor tissue and demonstrates its correlation with PD1-mediated signaling and clinical relevance.

ASSET quantifies aptamer specificity in enriched libraries using NGS, enabling accurate classification of true and false positives in SELEX processes.

AptamerRunner clusters aptamers by sequence and structure to create visual networks for selecting high-quality candidates for experimental validation.